Clinical Trial Update: Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy [Phase 2]

View source ↗

Summary

Phase 2 dose-finding safety study of remimazolam (CNS 7056) for procedural sedation in diagnostic upper GI endoscopy completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Procedural Sedation For Diagnostic Endoscopy

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: Paion UK Ltd. | Conditions: Procedural Sedation, Endoscopy | Phase 2 | Status: COMPLETED | Results posted: 2019-01-08